Acute tryptophan depletion alters gastrointestinal and anxiety symptoms in irritable bowel syndrome

American Journal of Gastroenterology

Volumn 101, Issue 11, 2006, Pages 2582-2587

  Shufflebotham, Jonathan ^a   Hood, Sean ^b   Hendry, Julie ^c   Hince, Dana A ^a   Morris, Kelly ^a   Nutt, David ^a   Probert, Chris ^a   Potokar, John ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN; TRYPTOPHAN;

ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABLE COLON; MALE; MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; TECHNIQUE;

ADULT; AFFECT; ANXIETY; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GASTROINTESTINAL TRACT; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; SEROTONIN; TRYPTOPHAN;

EID: 33750518608     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00811.x     Document Type: Article

References (34)

1. Saito YA, Schoenfeld P, Locke GR. The epidemiology of irritable bowel syndrome in North America: Systematic review. Am J Gastroenterol 2002;97:1910-5.
2. Lydiard RB. Irritable bowel syndrome, anxiety, and depression: What are the links? J Clin Psychiatry 2001;62(suppl 8):38-45.
3. Henningsen P, Zimmermann T, Sattel H. Medically unexplained physical symptoms, anxiety, and depression: A meta-analytic review. Psychosom Med 2003;65:528-33.
4. Young SN, Leyton M. The role of serotonin in human mood and social interaction. Insight from altered tryptophan levels. Pharmacol Biochem Behav 2002;71:857-65.
5. Crowell MD. Role of serotonin in the athophysiology of the irritable bowel syndrome. Br J Pharmacol 2004;141:1285-93.
6. Gershon MD. 5-Hydroxytryptamine in the physiology of the bowel. Aliment Pharmacol Ther 1999;13(suppl 2):15-30.
7. Nutt DJ. Overview of diagnosis and drug treatments of anxiety disorders. CNS Spectrums 2005;10:49-56.
8. Baker DE. Rationale for using serotonergic agents to treat irritable bowel syndrome. Am J Health Syst Pharm 2005;62:700-11.
9. Masand PS, Gupta S, Schwartz TL, et al. Does a preexisting anxiety disorder predict response to paroxetine in irritable bowel syndrome? Psychosomatics 2002;43:451-5.
10. Hood SD, Bell C, Nutt DJ. Acute tryptophan depletion. Part I: Rationale and methodology. Aust N Z J Psychiatry 2005;39:558-64.
11. Bell C, Hood SD, Nutt DJ. Acute tryptophan depletion. Part II: Clinical effects and implications. Aust N Z J Psychiatry 2005;39:565-74.
12. Booij L, Van der Does AJ, Riedel WJ. Monoamine depletion in psychiatric and healthy populations: Review. Mol Psychiatry 2003;8:951-73.
13. Carpenter LL, Anderson GM, Pelton GH, et al. Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology 1998;19:26-35.
14. Williams WA, Shoaf SE, Hommer D, et al. Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers. J Neurochem 1999;72:1641-7.
15. Kilkens TO, Honig A, van Nieuwenhoven MA, et al. Acute tryptophan depletion affects brain-gut responses in irritable bowel syndrome patients and controls. Gut 2004;53:1794-800.
16. Booij L, Van Der Does W, Benkelfat C, et al. Predictors of mood response to acute tryptophan depletion. A reanalysis. Neuropsychopharmacology 2002;27:852-61.
17. Bell C, Forshall S, Adrover M, et al. Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine. J Psychopharmacol 2002;16:5-14.
18. Argyropoulos SV, Hood SD, Adrover M, et al. Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder. Biol Psychiatry 2004;56:503-9.
19. Smith KA, Fairburn CG, Cowen PJ. Relapse of depression after rapid depletion of tryptophan. Lancet 1997;349:915-9.
20. Bond AJ, James DC, Lader MH. Physiological and psychological measures in anxious patients. Psychol Med 1974;4:364-73.
21. Spielberger CD. Manual for the State Trait Anxiety Inventory (STAI). Consulting Psychologists Press, Palo Alto, CA, 1983.
22. Steer RA, Beck AT, Brown G, et al. Self-reported depressive symptoms that differentiate recurrent-episode major depression from dysthymic disorders. J Clin Psychol 1987;43:246-50.
23. Dupont WD, Plummer WD Jr. Power and sample size calculations. A review and computer program. Control Clin Trials 1990;11:116-28.
24. Vasey MW, Thayer JF. The continuing problem of false positives in repeated measures ANOVA in psychophysiology: A multivariate solution. Psychophysiology 1987;24:479-86.
25. Muller-Lissner SA, Fumagalli I, Bardhan KD, et al. Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 2001;15:1655-66.
26. Camilleri M, Northcutt AR, Kong S, et al. Efficacy and safety of alosetron in women with irritable bowel syndrome: A randomised, placebo-controlled trial. Lancet 2000;355:1035-40.
27. Tack J, Broekaert D, Fischler B, et al. A controlled cross-over study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut 2006; Doi:10.1136/gut.2005.077503.
28. Masand PS, Gupta S, Schwartz TL, et al. Open-label treatment with citalopram in patients with irritable bowel syndrome: A pilot study. Prim Care Companion J Clin Psychiatry 2005;7:162-6.
29. Yeo A, Boyd P, Lumsden S, et al. Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut 2004;53:1452-8.
30. Heils A, Teufel A, Petri S, et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996;66:2621-4.
31. Crane C, Martin M, Johnston D, et al. Does depression influence symptom severity in irritable bowel syndrome? Case study of a patient with irritable bowel syndrome and bipolar disorder. Psychosom Med 2003;65:919-23.
32. Argyropoulos SV, Bailey JE, Hood SD, et al. Inhalation of 35% CO(2) results in activation of the HPA axis in healthy volunteers. Psychoneuroendocrinology 2002;27:715-29.
33. Tang J, Gibson SJ. A psychophysical evaluation of the relationship between trait anxiety, pain perception, and induced state anxiety. J Pain 2005;6:612-9.
34. Paffen ME, Kilkens TO, Honig A, et al. Does a rectal barostat procedure induce stress in IBS patients and healthy controls? Eur J Gastroenterol Hepatol 2003;15:A38.